{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:31:39Z","timestamp":1790281899185,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.urolonc.2026.07.005","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:31:47Z","timestamp":1786019507000},"page":"776-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9523-3400","authenticated-orcid":false,"given":"Leonardo","family":"Quarta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Petix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Filzmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan A.","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Micali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.urolonc.2026.07.005_bib0001","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","article-title":"Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience","volume":"81","author":"Reddy","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.005_bib0002","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eururo.2020.04.068","article-title":"The role of percentage of prostate-specific antigen reduction after focal therapy using high-intensity focused ultrasound for primary localised prostate cancer. Results from a large multi-institutional series","volume":"78","author":"Stabile","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.005_bib0003","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bju.14710","article-title":"Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer","volume":"124","author":"Stabile","year":"2019","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2026.07.005_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eururo.2025.06.003","article-title":"Irreversible electroporation for prostate tissue ablation in patients with intermediate-risk prostate cancer: results from the PRESERVE trial","volume":"89","author":"George","year":"2026","journal-title":"Eur Urol"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2026.07.005_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/bju.15946","article-title":"Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer","volume":"131","author":"Scheltema","year":"2023","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.005_bib0006","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JU.0000000000000506","article-title":"Focal therapy for localized prostate cancer with either high intensity focused ultrasound or cryoablation: a single institution experience","volume":"203","author":"Tourinho-Barbosa","year":"2020","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2026.07.005_bib0007","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/JU.0000000000001787","article-title":"Association between lesion location and oncologic outcomes after focal therapy for localized prostate cancer using either high intensity focused ultrasound or cryotherapy","volume":"206","author":"Stabile","year":"2021","journal-title":"J Urol"},{"issue":"24","key":"10.1016\/j.urolonc.2026.07.005_bib0008","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on prostate Cancer-2024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"S0302-2838","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2026.07.005_bib0009","author":"National Comprehensive Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.005_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/JU.0000000000002250","article-title":"Survival after radical prostatectomy versus radiation therapy in high-risk and very high-risk prostate cancer","volume":"207","author":"Chierigo","year":"2022","journal-title":"J Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2026.07.005_bib0011","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1002\/cncr.33584","article-title":"Cause of death during prostate cancer survivorship: a contemporary, US population-based analysis","volume":"127","author":"Weiner","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2026.07.005_bib0012","unstructured":"https:\/\/seer.cancer.gov\/archive\/manuals\/2022\/AppendixC\/Surgery_Codes_Prostate_2022.pdf."},{"issue":"8","key":"10.1016\/j.urolonc.2026.07.005_bib0013","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1200\/OP.23.00547","article-title":"Differences in rural versus urban patients with prostate cancer in diagnosis and treatment: an analysis of a population-based cohort","volume":"20","author":"Shen","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"8","key":"10.1016\/j.urolonc.2026.07.005_bib0014","first-page":"1085","article-title":"The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study","volume":"22","author":"Abdollah","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"2","key":"10.1016\/j.urolonc.2026.07.005_bib0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41391-020-00315-y","article-title":"Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched study","volume":"24","author":"Shah","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"10.1016\/j.urolonc.2026.07.005_bib0016","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.eururo.2024.11.006","article-title":"Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: the prospective, noninferiority, nonrandomized HIFI trial","volume":"87","author":"Ploussard","year":"2025","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143926005983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:20:59Z","timestamp":1789759259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143926005983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1078143926005983"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with focal therapy vs. radical prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2026.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}